Global Search

Hide Filters

Showing 1711 results

Biography / Jul 10, 2023

Michelle Weese
Careers in operations
Careers in research and development
Biography / Jun 25, 2025

Teresa Jose
Biography / Mar 04, 2025

Giovanni Caforio
Careers
Early careers
Press release / Sep 08, 2020

Novartis data at ACTRIMS-ECTRIMS highlight the strength of leading multiple sclerosis (MS) portfolio with life-changing therapies for people across the MS spectrum

Novartis will present 48 abstracts from its leading MS portfolio, including new data on recently FDA-approved Kesimpta® (ofatumumab)—the first and only self-administered, targeted B-cell therapy for…
Press release / Nov 19, 2020

New data at ASH to reinforce breadth of Novartis hematology portfolio across multiple blood cancers and serious hematologic diseases

Pivotal ASCEMBL study of novel, investigational STAMP inhibitor asciminib (ABL001) vs. bosutinib in CML patients previously treated with two or more TKIsELARA results for Kymriah® in relapsed or…
Press release / Oct 24, 2019

Novartis receives approval for Cosentyx® label update in Europe to include dosing flexibility in ankylosing spondylitis

New Cosentyx® (secukinumab) label to include 300 mg up-titration option is informed by results from the Phase III MEASURE 3 study[1] Approval provides clinicians with greater choice for their…